Integrase - PDFSEARCH.IO - Document Search Engine

Integrase
Results: 132

#	Item
11	PDF Document Add to Reading List Source URL: shionogi616.tew-staging.com Language: English - Date: 2014-11-03 11:26:09 ViiV Healthcare Intel Viiv Prescription Drug User Fee Act Shionogi Integrase inhibitor Food and Drug Administration Integrase Pharmaceutical sciences Pharmacology Clinical research
12	Microsoft Word - 20130218_FDA Priority Review Designation for DTG_E_Final Add to Reading List Source URL: shionogi616.tew-staging.com Language: English - Date: 2014-11-03 11:26:24 Pharmacology Integrase inhibitors HIV/AIDS Intel Viiv Shionogi ViiV Healthcare Integrase New Drug Application Prescription Drug User Fee Act Food and Drug Administration Pharmaceutical sciences Medicine
13	Shionogi-ViiV Healthcare LLC Initiates Phase III Clinical Programme for Investigational Once-Daily HIV Integrase Inhibitor Phase III Treatment-naïve and Treatment-experienced Trials Underway for S/GSK1349572 (‘572) Add to Reading List Source URL: shionogi616.tew-staging.com Language: English - Date: 2014-11-03 11:26:21 Health Medicine Integrase inhibitors GlaxoSmithKline ViiV Healthcare Lamivudine Pfizer Integrase Raltegravir Organofluorides Chemistry HIV/AIDS
14	Data from VIKING-3 Study, One of the Phase III Studies of the Integrase Inhibitor “Dolutegravir”, Disclosed by ViiV Healthcare Osaka, Japan, November 14, Shionogi & Co., Ltd. (Head Office: Osaka; President & C Add to Reading List Source URL: shionogi616.tew-staging.com Language: English - Date: 2014-11-03 11:26:18 Enzymes Integrase Microbiology Virology ViiV Healthcare Intel Viiv Shionogi Dolutegravir HIV Integrase inhibitors Biology Organofluorides
15	PDF Document Add to Reading List Source URL: shionogi616.tew-staging.com Language: English - Date: 2014-11-03 11:26:18 Medicine Intel Viiv Integrase ViiV Healthcare Shionogi New Drug Application HIV Food and Drug Administration Dolutegravir Integrase inhibitors Pharmaceutical sciences Biology
16	Shionogi-ViiV Healthcare Announces Initial Data from Pivotal Phase III Study of Dolutegravir in HIV SPRING-2 study meets primary endpoint of non-inferiority of dolutegravir compared to raltegravir over 48 weeks in treatm Add to Reading List Source URL: shionogi616.tew-staging.com Language: English - Date: 2014-11-03 11:26:24 Health Organic chemistry HIV/AIDS Amides Oxadiazoles Raltegravir Antiretroviral drug ViiV Healthcare GlaxoSmithKline Organofluorides Chemistry Integrase inhibitors
17	Microsoft Word - References for gene functions.docx Add to Reading List Source URL: phagesdb.org Language: English - Date: 2012-11-12 21:32:31 Virology Intein Protein biosynthesis Integrase Biology Microbiology Enzymes
18	IHCP bulletin INDIANA HEALTH COVERAGE PROGRAMS BT201525 APRIL 16, 2015 Add to Reading List Source URL: www.indianamedicaid.com Language: English - Date: 2015-04-16 16:14:04 Organic chemistry Fixed dose combination Medicine Integrase inhibitors Purines Tenofovir/emtricitabine Emtricitabine Tenofovir Raltegravir Gilead Sciences Organofluorides Chemistry
19	Microsoft Word - Fig1.docx Add to Reading List Source URL: pfwww.kek.jp Language: English - Date: 2013-12-17 02:13:23 Antivirals Cytokines Interferon Virus Gene expression Gene Ras subfamily Integrase RNA interference Biology Molecular biology RNA
20	AETC_Logo_trnsp_nkgrnd-bw Add to Reading List Source URL: www.amc.edu Language: English - Date: 2015-03-20 17:38:35 Gilead Sciences Pharmacology Fixed dose combination Integrase inhibitors Carbamates Antiretroviral drug Tenofovir/emtricitabine Tenofovir Emtricitabine/tenofovir/efavirenz Chemistry Organic chemistry Organofluorides

UPDATE